Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03765736 · ClinicalTrials.gov registry record
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
A clinical trial, sponsored by Academic and Community Cancer Research United.
- Terminated
- Registry status
- 199
- Enrollment target
NCT03765736 is a clinical trial that was terminated before completion, run by Academic and Community Cancer Research United. The registered enrollment target is 199 participants.
The verdict
NCT03765736 was terminated before completion, sponsored by Academic and Community Cancer Research United.
- TERMINATED
- Registry status
- 199 participants
- Enrollment target
Study Summary
This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.
Interventions
- OTHER Genetic Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2020-04-20 |
| Est. Completion | 2023-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03765736
The ClinicalTrials.gov registry entry for NCT03765736 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Academic and Community Cancer Research United, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic Testing is the first listed.
NCT03765736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03765736 about?
NCT03765736 is a clinical study titled "Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial". This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target ...
What is the current status of trial NCT03765736?
This trial is currently terminated. The enrollment target is 199 participants. The study started on 2020-04-20. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT03765736?
The interventions under investigation include: Genetic Testing (OTHER).
Who is sponsoring clinical trial NCT03765736?
This trial is sponsored by Academic and Community Cancer Research United, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.